dawnrays pharmaceutical hold
(2348:Stock Exchange of Hong Kong Limited)
Kei Ling Li
Co-Founder, Chairman, Chairman of Nomination Committee and Member of Remuneration Committee,Dawnrays Pharmaceutical Holdings Ltd.
|Age||Total Calculated Compensation||This person is connected to 7 board members in 1 different organizations across 1 different industries.|
See Board Relationships
As of Fiscal Year 2015
Ms. Kei Ling Li is a Co-Founder of Dawnrays Pharmaceutical Holdings Ltd., and served as its Chief Executive Officer since March 1, 2015 until April 18, 2016. Ms. Li served as Head of Corporate Development at Dawnrays Pharmaceutical Holdings Ltd., since March 1, 2015. She is responsible for the overall planning and implementation of corporate development, financial management and strategies formulation of the Dawnrays Pharmaceutical. Ms. Li has over 20 years of experience ...
CNT TowerPhone: --
Wanchai, -- --
Board Members Memberships*
Co-Founder, Chairman, Chairman of Nomination Committee and Member of Remuneration Committee
Education*There is no Education data available.
Other Affiliations*There is no Company Affiliations data available.
The information and data displayed in this profile are created and managed by S&P Global Market Intelligence, a division of S&P Global. Bloomberg.com does not create or control the content. For inquiries, please contact S&P Global Market Intelligence directly by clicking here.
|There is no Competitor Compensation data available.|
Sponsored Financial Commentaries
Only a company representative may request an update for the company profile. Documentation will be required.